Scientists hail injectable drug for HIV prevention

Original Article by Ina Skosana | Health-e News | 26 June 2024

Early results from the PURPOSE 1 trial show that an injectable antiretroviral drug can prevent HIV infection in cisgender women, marking a historic breakthrough.

Early results from the PURPOSE 1 trial show that an injectable antiretroviral drug can prevent HIV infection in cisgender women, marking a historic breakthrough.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here